Gregory GA, Robinson TIG, Linklater SE et al (2022) Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol 10(10):741–760. https://doi.org/10.1016/S2213-8587(22)00218-2

Article  PubMed  Google Scholar 

Zhong T, Tang R, Xie Y, Liu F, Li X, Zhou Z (2020) Frequency, clinical characteristics, and determinants of partial remission in type 1 diabetes: Different patterns in children and adults. J Diabetes 12(10):761–768. https://doi.org/10.1111/1753-0407.13044

Article  CAS  PubMed  Google Scholar 

Mortensen HB, Hougaard P, Swift P et al (2009) New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 32(8):1384–1390. https://doi.org/10.2337/dc08-1987

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kahkoska AR, Adair LA, Aiello AE et al (2019) Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c. Pediatr Diabetes 20(5):556–566. https://doi.org/10.1111/pedi.12856

Article  CAS  PubMed  PubMed Central  Google Scholar 

Committee ADAPP (2022) Glycemic targets: Standards of medical care in diabetes-2022. Diabetes Care 45(Suppl 1):S83-s96. https://doi.org/10.2337/dc22-S006

Article  Google Scholar 

Bergenstal RM, Beck RW, Close KL et al (2018) Glucose management indicator (GMI): A new term for estimating A1C from continuous glucose monitoring. Diabetes Care 41(11):2275–2280. https://doi.org/10.2337/dc18-1581

Article  PubMed  PubMed Central  Google Scholar 

Kazda CM, Bue-Valleskey JM, Chien J et al (2023) Novel once-weekly basal insulin Fc achieved similar glycemic control with a safety profile comparable to insulin degludec in patients with type 1 diabetes. Diabetes Care 46(5):1052–1059. https://doi.org/10.2337/dc22-2395

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pollé OG, Delfosse A, Martin M et al (2022) Glycemic variability patterns strongly correlate with partial remission status in children with newly diagnosed type 1 diabetes. Diabetes Care 45(10):2360–2368. https://doi.org/10.2337/dc21-2543

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klonoff DC, Wang J, Rodbard D et al (2022) A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings. J Diabetes Sci Technol 17(5):1226–1242. https://doi.org/10.1177/19322968221085273

Article  PubMed  PubMed Central  Google Scholar 

de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85(9):660–667. https://doi.org/10.2471/blt.07.043497

Article  PubMed  PubMed Central  Google Scholar 

Li X, Zhong T, Tang R et al (2020) PD-1 and PD-L1 expression in peripheral CD4/CD8+ T cells is restored in the partial remission phase in type 1 diabetes. J Clin Endocrinol Metab 105(6):dgaa130. https://doi.org/10.1210/clinem/dgaa130

Article  PubMed  Google Scholar 

Shi M, Xie Y, Tang R, Zhong T, Zhou Z, Li X (2021) Three-phasic pattern of C-peptide decline in type 1 diabetes patients with partial remission. Diabetes Metab Res Rev 37(8):e3461. https://doi.org/10.1002/dmrr.3461

Article  CAS  PubMed  Google Scholar 

Vigers T, Chan CL, Snell-Bergeon J et al (2019) cgmanalysis: an R package for descriptive analysis of continuous glucose monitor data. PLoS One 14(10):e0216851. https://doi.org/10.1371/journal.pone.0216851

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Lu J, Shen Y et al (2022) Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients. J Diabetes Investig 13(9):1543–1550. https://doi.org/10.1111/jdi.13811

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie Y, Liu F, Huang F et al (2020) Establishment of a type 1 diabetes structured education programme suitable for Chinese patients: type 1 diabetes education in lifestyle and self adjustment (TELSA). BMC Endocr Disord 20(1):37. https://doi.org/10.1186/s12902-020-0514-9

Article  PubMed  PubMed Central  Google Scholar 

Lin T, Zhao R, Tu S, Wu H, Zhang H, Tu XM (2023) On modelling relative risks for longitudinal binomial responses: implications from two dueling paradigms. Gen Psychiatr 36(2):e100977. https://doi.org/10.1136/gpsych-2022-100977

Article  PubMed  PubMed Central  Google Scholar 

Brusko TM, Russ HA, Stabler CL (2021) Strategies for durable β cell replacement in type 1 diabetes. Science 373(6554):516–522. https://doi.org/10.1126/science.abh1657

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang J, Gong X, Chen S et al (2023) Development of smartphone-controlled and microneedle-based wearable continuous glucose monitoring system for home-care diabetes management. ACS Sens 8(3):1241–1251. https://doi.org/10.1021/acssensors.2c02635

Article  CAS  PubMed  Google Scholar 

Addala A, Ding V, Zaharieva DP et al (2023) Disparities in hemoglobin A1c levels in the first year after diagnosis among youths with type 1 diabetes offered continuous glucose monitoring. JAMA Netw Open 6(4):e238881. https://doi.org/10.1001/jamanetworkopen.2023.8881

Article  PubMed  PubMed Central  Google Scholar 

Donaldson LE, Vogrin S, So M et al (2023) Continuous glucose monitoring-based composite metrics: a review and assessment of performance in recent-onset and long-duration type 1 diabetes. Diabetes Technol Ther 25(7):497–506. https://doi.org/10.1089/dia.2022.0563

Article  CAS  PubMed  Google Scholar 

Alonso GT, Triolo TM, Akturk HK et al (2023) Increased technology use associated with lower A1C in a large pediatric clinical population. Diabetes Care 46(6):1218–1222. https://doi.org/10.2337/dc22-2121

Article  PubMed  Google Scholar 

Beck RW, Riddlesworth T, Ruedy K et al (2017) Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA 317(4):371–378. https://doi.org/10.1001/jama.2016.19975

Article  CAS  PubMed  Google Scholar 

Rickels MR, Evans-Molina C, Bahnson HT et al (2020) High residual C-peptide likely contributes to glycemic control in type 1 diabetes. J Clin Invest 130(4):1850–1862. https://doi.org/10.1172/JCI134057

Article  CAS  PubMed  PubMed Central  Google Scholar 

Battaglia M, Ahmed S, Anderson MS et al (2020) Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes. Diabetes Care 43(1):5–12. https://doi.org/10.2337/dc19-0880

Article  PubMed  Google Scholar 

Shah VN, Sakamoto C, Pyle L (2023) Optimal sampling duration for continuous glucose monitoring for the estimation of glycemia risk index. Diabetes Technol Ther 25(2):140–142. https://doi.org/10.1089/dia.2022.0401

Article  CAS  PubMed  Google Scholar